HQY 📈 HealthEquity - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US42226A1079
HQY: Health, Savings, Accounts, Investment, Benefits, Advisory, Platforms
HealthEquity Inc, a company listed on the NASDAQ under the ticker symbol HQY, operates a range of technology-enabled services platforms designed to empower consumers and employers in the United States to make informed decisions about their health savings and spending. The company's cloud-based platforms provide individuals with a comprehensive suite of tools to manage their health savings accounts, pay healthcare bills, and access personalized benefit information, as well as earn wellness incentives and make investment choices. This platform essentially serves as a one-stop-shop for individuals seeking to optimize their health savings and investment strategies.
One of the key offerings of HealthEquity Inc is its investment platform, which is complemented by online-only automated investment advisory services through a web-based tool known as Advisor. This tool is designed to provide users with expert guidance on investment decisions, further enhancing the company's suite of services. Additionally, HealthEquity Inc offers a range of other financial products and services, including flexible spending accounts, health reimbursement arrangements, and Consolidated Omnibus Budget Reconciliation Act continuation services. The company also administers pre-tax commuter benefit programs, underscoring its commitment to providing a broad spectrum of benefits administration services.
In terms of its operational structure, HealthEquity Inc serves its clients through a multi-channel approach, leveraging a direct sales force, benefits brokers and advisors, and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. This diversified approach enables the company to reach a wide range of clients and provide tailored services that meet their specific needs. With its incorporation in 2002 and headquarters in Draper, Utah, HealthEquity Inc has established itself as a significant player in the managed health care sector, with its common stock listed under the ISIN US42226A1079 and classified under the GICS Sub Industry of Managed Health Care.
Additional Sources for HQY Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HQY Stock Overview
Market Cap in USD | 8,074m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Managed Health Care |
IPO / Inception | 2014-07-31 |
HQY Stock Ratings
Growth 5y | 32.4% |
Fundamental | 38.8% |
Dividend | - |
Rel. Strength Industry | 6308 |
Analysts | 4.5/5 |
Fair Price Momentum | 93.05 USD |
Fair Price DCF | 58.74 USD |
HQY Dividends
No Dividends PaidHQY Growth Ratios
Growth Correlation 3m | 65.7% |
Growth Correlation 12m | 52.3% |
Growth Correlation 5y | 44.8% |
CAGR 5y | 5.86% |
CAGR/Mean DD 5y | 0.23 |
Sharpe Ratio 12m | 1.11 |
Alpha | 18.18 |
Beta | 0.86 |
Volatility | 34.61% |
Current Volume | 551.8k |
Average Volume 20d | 850.9k |
As of January 03, 2025, the stock is trading at USD 95.95 with a total of 551,839 shares traded.
Over the past week, the price has changed by -1.50%, over one month by -5.62%, over three months by +19.53% and over the past year by +45.01%.
Partly, yes. Based on ValueRay Fundamental Analyses, HealthEquity (NASDAQ:HQY) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.84 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HQY as of January 2025 is 93.05. This means that HQY is currently overvalued and has a potential downside of -3.02%.
HealthEquity has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy HQY.
- Strong Buy: 8
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, HQY HealthEquity will be worth about 102.5 in January 2026. The stock is currently trading at 95.95. This means that the stock has a potential upside of +6.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 113 | 17.8% |
Analysts Target Price | 85.9 | -10.5% |
ValueRay Target Price | 102.5 | 6.8% |